Clinical trial
Smell in COVID-19 and Efficacy of Nasal Theophylline 3
NCT05947643 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smell in COVID-19 and Efficacy of Nasal Theophylline 3
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 22, 2022
- Completion date
- August 4, 2025
- Enrollment
- 77 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.